Skip to main content
. 2023 May 29;14:1126217. doi: 10.3389/fimmu.2023.1126217

Figure 3.

Figure 3

Protein abundance assays and differential analysis of 16 immune-related proteins and hemoglobin were performed in validation cohort I. Validation cohort I (n = 343) included 192 CRC patients (red) and 151 HCs (blue), with each dot representing one sample. The unpaired Wilcoxon rank test was used to analyze differences in protein abundance. * P< 0.05, *** P< 0.001, **** P< 0.0001, ns, not significant.